Compugen Ltd. (CGEN) Financials

CGEN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 145.9 million 50.5 million
Dec. 31, 2025 156.9 million 54.1 million
Sept. 30, 2025 97.8 million 54.0 million
June 30, 2025 106.5 million 56.3 million

CGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 31.3 million ?
Sept. 30, 2025 ? ?
June 30, 2025 ? ?

CGEN Net Income

No data available :(

CGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 134.9 million - 2.4 million
Dec. 31, 2025 145.6 million - 2.4 million
Sept. 30, 2025 86.1 million - 2.9 million
June 30, 2025 93.9 million - 3.0 million

CGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 94.6 million
Dec. 31, 2025 94.7 million
Sept. 30, 2025 93.5 million
June 30, 2025 93.5 million

CGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 6.9 million 2.4 million 134000
Dec. 31, 2025 306000 5.5 million 2.2 million 120000
Sept. 30, 2025 - 5.8 million 2.3 million 139000
June 30, 2025 - 5.6 million 2.4 million 141000

CGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.2 million 1.8 million
Dec. 31, 2025 67.3 million 3.5 million
Sept. 30, 2025 1.9 million 1.7 million
June 30, 2025 1.3 million 1.7 million

CGEN

Price: $2.10

52 week price:
1.23
3.24

Earnings Per Share: 0.38 USD

P/E Ratio: 7.37

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 1.0 million

Ebitda: -10.0 million

Market Capitalization: 264.8 million

Links: